Search
Viking Therapeutics Inc
VKTXAdd to Watchlist
30.380USD
+0.090+0.30%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
3.52BMarket Cap
LossP/E TTM
Viking Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Viking Therapeutics Inc is 7.91, ranking 182 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -7.31, which is -8.66% below the recent high of -6.68 and -1319.58% above the recent low of -103.80.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
